[Excretion of 17-ketosteroid fractions in leukemic patients following ACTH therapy].
D015065:17-Hydroxycorticosteroids / Q000652:urine*; D015068:17-Ketosteroids / Q000652:urine*; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000738:Androsterone / Q000652:urine; D003687:Dehydroepiandrosterone / Q000652:urine; D005043:Etiocholanolone / Q000652:urine; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000652:urine*; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000652:urine*; D007951:Leukemia, Myeloid / Q000652:urine*; D015470:Leukemia, Myeloid, Acute / Q000652:urine; D008297:Male; D008875:Middle Aged
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D003687:Dehydroepiandrosterone; D000324:Adrenocorticotropic Hormone; D005043:Etiocholanolone; D000738:Androsterone
Die Ausscheidung der 17-Ketosteroid-Fraktionen bei Leukämiekranken nach ACTH-Behandlung.